Ananth Kadambi outlines how clinical operations teams can plan for FDA’s OS requirements—enhancing patient tracking…

Discover how real-world evidence and predictive modeling strengthen OS-focused trial designs in oncology, improving efficiency…

Ananth Kadambi shares how model-informed drug development helps sponsors predict efficacy and align shorter oncology…

Ananth Kadambi explains how FDA’s emphasis on overall survival reshapes oncology drug trial success metrics…

In this ACT interview, Certara’s Ananth Kadambi discusses the operational hurdles sponsors face as FDA…